CJ Bioscience to Relocate Headquarters Within Seoul on Dec. 7, 2026

• CJ Bioscience plans to relocate its headquarters within Seoul on Dec. 7, 2026, to improve its operating environment and efficiency.
• The new headquarters will occupy the third floor of the CJ CheilJedang Center at 330 Dongho-ro, Jung-gu.
• The board authorized the move on Nov. 10, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CJ Bioscience Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261110900718), on November 10, 2026, and is solely responsible for the information contained therein.